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Abstract 
Purpose:  International consensus has not been reached regarding the optimal number 
of implanted tumour bed (TB) markers for partial breast/ breast boost radiotherapy 
target volume delineation. Four common methods are: insertion of 6 clips (4 radial, 1 
deep and 1 superficial), 5 clips (4 radial and 1 deep), 1 clip at the chest wall, and no 
clips. We compared TB volumes delineated using 6, 5, 1 and 0 clips in women who 
have undergone wide-local excision (WLE) of breast cancer (BC) with full-thickness 
closure of the excision cavity, in order to determine the additional margin required for 
breast boost or partial breast irradiation (PBI) when fewer than 6 clips are used. 
Methods: Ten patients with invasive ductal BC who had undergone WLE followed by 
implantation of six fiducial markers (titanium clips) each underwent CT imaging for 
radiotherapy planning purposes. Retrospective processing of the DICOM image 
datasets was performed to remove markers and associated imaging artefacts, using an 
in-house software algorithm. Four observers outlined TB volumes on four different 
datasets for each case: 1) all markers present (CT6M); 2) the superficial marker 
removed (CT5M); 3) all but the chest wall marker removed (CTCW); 4) all markers 
removed (CT0M). For each observer, the additional margin required around each of 
TB0M, TBCW, and TB5M in order to encompass TB6M was calculated. The conformity level 
index (CLI) and differences in centre-of-mass (COM) between observers were 
quantified for CT0M, CTCW, CT5M, CT6M. 
Results: The overall median additional margins required to encompass TB6M were 
8mm (range 0-28mm) for TB0M, 5mm (range 1-13mm) for TBCW, and 2mm (range 0-
7mm) for TB5M. CLI were higher for TB volumes delineated using CT6M (0.31) CT5M 
(0.32) than for CTCW (0.19) and CT0M (0.15).  
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Conclusions: In women who have undergone WLE of breast cancer with full-thickness 
closure of the excision cavity and who are proceeding to PBI or breast boost RT, target 
volume delineation based on 0 or 1 implanted markers is not recommended as large 
additional margins are required to account for uncertainty over true TB location. Five 
implanted markers (one deep and four radial) are likely to be adequate assuming 
addition of a standard 10-15mm TB-CTV margin. Low CLI values for all TB volumes 
reflect the sensitivity of low volumes to small differences in delineation and are unlikely 
to be clinically significant for TB5M and TB6M.in the context of adequate TB-CTV 
margins. 
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Introduction 
Whole breast radiotherapy (WBRT) following breast-conserving surgery (BCS) 
improves local control and survival (1, 2) but is associated with increased non-breast-
cancer-related mortality and morbidity due to irradiation of non-target tissue (2, 3).  A 
strategy that aims to improve the therapeutic ratio in women at relatively low risk of 
local tumour relapse involves limiting high radiation doses to the index quadrant and 
reducing or eliminating dose to breast tissue remote from the tumour bed (TB) (4, 5). An 
essential prerequisite of external beam partial breast irradiation (PBI) is accurate 
localization of the TB, for which many oncologists are using CT imaging. However, CT 
imaging alone has been found to be associated with significant interobserver variability 
(IOV) (6-8) particularly in patients with low-volume seroma (6). Full-thickness apposition 
of tumour cavity walls following wide local excision is an increasingly common surgical 
practice based on evidence that it reduces the risk of post-operative infection (9), 
increases the sensitivity of mammography to detect local recurrence (9), and reduces 
exposure of cavity walls to potentially tumorigenic wound fluids (10). Full-thickness 
apposition of cavity walls is likely to decrease the incidence of seroma formation and to 
increase uncertainty over TB localization using CT-imaging alone. Furthermore, seroma 
alone may underestimate the true TB volume and misrepresent its shape (11, 12). 
Markers implanted in surgical cavity walls provide additional localization information 
compared to kV-CT-imaging alone (13), such that CT and marker-based TB delineation 
has been recommended as the current gold standard (14). Despite this, the use of 
implanted fiducial markers is still not widespread.  
Where markers are in use, the optimal number of implanted markers remains unclear. 
Evidence suggests that the use of CT plus fewer than three clips is likely to significantly 
underestimate the extent of the TB (13, 15). A UK protocol recommends that paired 
clips be inserted into the four radial, the deep and the superficial margins of excision 
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(16) but, having established that clips do not migrate, more recent studies recommend 
placement of six markers (four radial, a chest wall and a superficial marker) (17). Many 
surgeons however prefer not to place a superficial clip due to concerns over marker 
mobility, cosmesis and marker palpability.  
Within-patient comparison of TB volumes delineated using different numbers of markers 
would be valuable in illustrating the clinical implications of using fewer than six TB 
markers. Such a comparison has only recently been made possible through 
development of computer software capable of removing markers from CT images. This 
study compares TB volumes delineated by four observers using CT plus 0 (TB0M), 1 
(TBCW), 5 (TB5M), or 6 (TB6M) markers in a population of breast cancer patients who 
have undergone WLE with full-thickness closure of the tumour cavity. For each 
observer, the additional margin required around each of TB0M, TBCW, and TB5M in order 
to encompass TB6M is calculated. It is hypothesised that progressively larger margins 
will be required as the number of markers decreases. In addition, the conformity level 
index and differences in centres-of-mass (COM) between observers’ volumes are 
calculated for each of 0, 1, 5, and 6 markers. It is hypothesised that conformity level 
indices will decrease and that differences in COM will increase with decreasing 
numbers of markers. 
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Methods 
Eligibility 
Eligible patients were recruited via an ethically-approved study in which wide local 
excision of invasive ductal carcinoma of the breast was followed by placement of six 
titanium clips according to a national protocol (17), one at each of the four radial, the 
deep and the superficial excision margins. All patients had undergone full-thickness 
closure of the tumour cavity.  
Imaging 
All patients underwent kV-CT-imaging for radiotherapy in a supine position with the 
arms extended and abducted over the head, immobilised on a semi-supine breast 
board. All imaging datasets were graded for seroma visibility by observer AK using a 
cavity visualisation score (CVS) which ranges from 1 (cavity invisible) to 5 (cavity 
borders clearly identifiable) (6). Four anonymised copies were made of each dataset. 
One dataset per patient was left unaltered and labelled CT plus 6 markers (CT6M).  
On the remaining three datasets, markers were removed from CT images by a single 
independent radiation oncologist (RJ) using the following algorithm. The CT data was 
displayed as a grey scale image to the user, with a cross hair to identify the location of 
the marker to be removed (the “target”). The user identified a second region in the CT 
which had approximately the same structure as the tissue around the target. By 
sampling from this region, the user was able to gradually replace the target with tissue 
of a similar density to that surrounding the target. The algorithm is similar to the 'Clone-
stamp' tool found in popular image processing algorithms such as Adobe PhotoshopTM 
(Adobe Systems, San Jose, California, USA), but coded to operate on the Hounsfield 
Unit (HU) values in the CT dataset rather than the grey scale representation. The 
algorithm was used to remove TB markers, and to remove any local streaking artefacts 
in the region of the markers. 
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Using this software on the second dataset, only the most superficial marker was 
removed from the dataset. This dataset was labelled CT plus 5 markers (CT5M). On the 
third dataset, all markers except that closest to the chest wall were removed. This 
dataset was labelled CT plus chest wall marker (CTCW). On the fourth dataset, all 
markers were removed and this was labelled CT with 0 markers (CT0M). Data before 
and after clip removal is shown in figure 1. 
 
TB delineation 
Four separate observers (observers 1-4, all radiation oncologists) outlined TB volumes 
on all four datasets for each of the ten patients. All observers were given guidelines for 
TB delineation as follows: using CT alone, observers were advised to include as TB any 
visible seroma and associated changes in tissue architecture. Using CT and markers, 
observers were advised to include as TB any visible markers, together with any visible 
seroma or change in the surrounding tissue architecture. All delineation was performed 
with a fixed window level of 0 HU and width of 500 HU. In each case, observers 
outlined CT0M first, followed by CTCW, then CT5M and finally CT6M. Observers were 
blinded to the delineated TB volumes of other observers. All observers had outlined a 
single test case which was reviewed prior to commencing the study to ensure that 
guidelines were being followed. An independent observer was asked to define marker 
position on CT0M of cases 1-3 in order to test the axiom that markers were satisfactorily 
obscured. 
Clinical and planning target volume (CTV) definition 
Based on the UK IMPORT LOW trial protocol (18), clinical target volumes (CTV) were 
created by adding a uniform 15mm margin to each TB in 3-dimensions, limited deeply 
by chest wall and superficially by 5mm beneath skin surface. Planning target volumes 
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were created by expanding the CTV by a 10mm 3-dimensional margin (limited by 5mm 
from skin).  
Analysis 
For each observer, the additional margin required around each of TB0M, TBCW, and TB5M 
in order to encompass that observer’s TB6M was calculated for each of the ten cases in 
each of the medial, lateral, anterior, posterior, superior and inferior directions (see figure 
2). Median additional margins were calculated for each of TB0M, TBCW, and TB5M. If 
TB6M was encompassed by any of the other TB volumes in any direction, this margin 
was set to zero. Differences in centres-of-mass (COM) between TB6M and each of the 
other TB volumes were calculated. 
TB volumes were quantified. The conformity level index (CLI) for each dataset was 
calculated according to methodology defined by Kouwenhoven et al (19). The 
conformity level index is a variation on the conformity index (defined as the ratio of 
common volume to encompassing volume). The CLI performs pairwise comparisons, 
expressing the sum of all pairwise overlaps as a fraction of the sum of all encompassing 
volumes. The CLI is independent of the number of observers and is therefore 
considered more suitable for comparison between studies using different numbers of 
observers. CLI calculations were carried out using a modified version of software for 
comparison of multiple radiotherapy contours (COAST (Cambridge Outline Analysis 
and Scoring Tool) (20)).  
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Results 
Ten patients were recruited, all of whom had undergone full-thickness closure of the 
tumour cavity with insertion of one clip at each of the four radial, the deep and the 
superficial margins. Median age was 54 years (range 41-65 years). Five patients had 
CVS= 1 and five had CVS= 2. Examples of TB contours are displayed in figure 3.  
Table 1 details the additional margins that would have been required around TB 
volumes delineated using fewer than 6 clips in order to encompass TB6M. There was no 
overlap at all between TB0M and TB6M for case 1 (observers 3 and 4), case 7 (observer 
1), and case 9 (observer 2). For all other comparisons, there was some overlap 
between TB volumes. The overall median additional margin required was 8mm (range 
0-28mm) for TB0M, 5mm (range 1-13mm) for TBCW, and 2mm (range 0-7mm) for TB5M.  
Table 2 displays median differences in TB COM. Median CLIs for each of the 
delineation methods are displayed in table 3. Median TB volumes for each observer are 
listed in table 4. Observers 1 and 2 outlined significantly larger volumes than observers 
3 and 4. The independent observer was unable to locate any markers on obfuscated 
datasets. Her best guesses did not match with marker location on any of the three 
datasets analysed suggesting that markers had been satisfactorily removed from CT 
datasets. 
 
Discussion 
This study set out to compare tumour bed (TB) volumes delineated using 0, 1, 5 and 6 
clips in women who have undergone wide-local excision (WLE) of breast cancer (BC), 
in order to determine the additional margin required when fewer than 6 clips are used. 
When TB volumes were outlined using no clips or a single chest wall clip, median 
additional margins of 8mm and 5mm respectively were required in order to encompass 
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TB6M. Indeed, 4/10 TB0M completely geographically missed TB6M. This finding appears 
to be independent of observers as each observer geographically missed one TB using 
CT alone. Such uncertainty over TB location means that TB delineation using CT alone 
cannot be recommended for PBI. Where breast boost radiotherapy is being planned 
without TB markers, our study found that additional margins of up to 28mm and 13mm 
for TB0M and TBCW respectively would have been required in order to encompass the 
true marker-defined TB6M. Differences in centres-of-mass reflected and supported the 
margin findings, being greatest (up to 37mm difference) for TB0M versus TB6M. The 
additional margins would translate to a significant increase in breast boost field size 
with implications for late side-effects. For example, Cox et al (21) found that for every 
5mm increase in CTV-PTV margins, there was a 15% increase in the mean ipsilateral 
breast dose, and that for a 10mm increase in CTV-PTV margins, the mean heart dose 
doubled (from 23-43cGy) and mean lung doses tripled (from 61 to 180cGy). In short, TB 
delineation for either PBI or breast boost radiotherapy using CT alone or a single chest 
wall marker cannot be recommended as, without an additional margin, accuracy is 
compromised and, with an additional margin, normal tissue doses are significantly 
increased.  
Where TB volumes were outlined using five clips (the most superficial having been 
removed from the CT images), the differences between TB5M and TB6M were, as 
expected, negligible in all but the anterior direction. (Previous work suggests that a 
median difference between observers of around 1-2mm is an acceptable level of 
variation between expert observers (22)). The median additional anterior margin 
required was 4mm (maximum 7mm). This is unlikely to be clinically significant in the 
context of mini-tangential field arrangements for PBI, as these usually splash the skin 
surface. However, where more conformal field arrangements are used, an additional 
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small margin (4-5mm) to ensure adequate coverage of the anterior aspect of target 
tissue may be advisable. 
The methodology of performing the margin analyses within each observer’s own 
volumes was designed to distinguish differences between TB delineation methods from 
differences between observers. Interobserver variability (IOV) however also reflects 
uncertainties in target volume delineation and should be accounted for in CTV-PTV 
margins. Hurkmans et al (23) previously reported conformity indices (CoI) of between 
0.11 and 0.52 for ten TB volumes outlined by four different observers. These CoIs were 
low in comparison to the CoI of 0.8 that is suggested to be an acceptable level of 
variation amongst expert observers (22). Patients in Hurkmans’ study (23) did not have 
TB markers but, judging from the high average initial TB volume (40cm3), tumour 
cavities had been closed only superficially such that CVS is likely to have been high on 
initial CT scanning. IOV has been reported to increase with decreasing visibility of the 
tumour cavity (6), Landis et al having found a median percentage PTV overlap of 57% 
for cavities with CVS=2 versus 87% for cavities with CVS=5. It has been hypothesised 
that TB markers might reduce IOV although Struikmans et al (8), who reported IOV 
between five observers outlining 17 cases, found no difference in conformity indices for 
patients with clips (n=8, CoI=0.56) and without clips (n=9, CoI=0.55). CVS was not 
measured in this study. 
Our study did find a relationship between markers and conformity level indices (CLI). 
CLI were almost double for TB volumes delineated using 5 or 6 markers than for those 
delineated using 1 or 0 markers suggesting that markers do reduce uncertainty in target 
volume delineation. That said, CLI were low even for TB6M in comparison to those 
previously reported (6, 8, 23). Table 4 demonstrates that there were significant 
differences in median TB volumes between observers. Observers 1 and 2 outlined, on 
average, larger TB volumes than did observers 3 and 4. The reasons for this are 
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unclear. All observers followed the protocol and no significant volumetric differences 
were detected on the test case. Qualitative review of TB volumes suggests that 
observers 3 and 4 conformed much more tightly to TB markers than did observers 1 
and 2. Interestingly, observers 1 and 2 worked at one institution and observers 3 and 4 
at another. Observers 1 and 2 had more experience with gold seeds (which generate 
more artefact and therefore more uncertainty as to their boundaries) and with 
superficially-closed cavities whilst observers 3 and 4 had more experience with titanium 
clips and full-thickness closure of cavities. 
Limitations of this study are as follows. Firstly, all cases had undergone full-thickness 
closure of the excision cavity as reflected by the low CVS. This accounts for the very 
low CLI for cases with 0 or 1 markers. The conclusions of this study are therefore only 
applicable to this patient group and cannot be applied to patients who have undergone 
superficial cavity closure, in whom seroma is likely to be more easily visualised and 
more consistently outlined. It is likely that in such patients, the risk of geographical miss 
without TB markers would be much lower. Secondly, large volumetric differences exist 
between observers. These have resulted in universally low CLI but are unlikely to have 
affected conclusions regarding margins. Thirdly, it is likely that differences in TB 
volumes will be greater than differences between clinical target volumes given that 
volumes are truncated at the peripheries of breast tissue. A similar comparison of 
differences in CTV0M, CTVCW, CTV5M and CTV6M would be of interest. Fourthly, the 
markers may have been inadequately obscured on the CT datasets although this 
seems unlikely given that the independent observer failed to identify any markers on 
obscured datasets, and that each observer completely geographically missed one TB 
volume using CT alone. Finally, sample size was small. Ten further cases with full-
thickness closure are currently being processed alongside ten cases with superficially-
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closed cavities. This will improve confidence in the findings as well as broadening their 
applicability. 
In conclusion, in women who have undergone WLE of breast cancer with full-thickness 
closure of the excision cavity and who are proceeding to PBI or breast boost RT, target 
volume delineation based on 0 or 1 implanted markers is not recommended as large 
additional margins would be required to account for uncertainty over true TB location. 
Five implanted markers (one deep and four radial) are likely to be adequate for the 
purposes of TB delineation for partial breast/ breast boost radiotherapy using tangential 
fields. Six implanted markers are preferable where more conformal techniques are 
employed. 
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Figure legends 
 
Figure 1. Axial CT image from a single case a) before and b) after removal of 
tumour bed titanium clips  
 
 
Figure 2. Diagram illustrating methodology for margin calculations (by 
convention, margin =0mm where TB0M is outside TB6M) 
 
 
Figure 3. Equivalent axial and sagittal CT slices from a single patient 
demonstrating the four observers’ outlines (red, yellow, green & blue) for a)TB0M, 
b)TBCW, c)TB5M, 4)TB6M demonstrating increased conformality between observers 
as number of markers increases. 
Tumour bed markers                                                                                   Kirby page  
 
18 
 
Figure 1. 
  
 
a b 
Tumour bed markers                                                                                   Kirby page  
 
19 
Figure 2.  
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Figure 3. 
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Table 1: Median additional margins required to encompass TB6M (mm) (range) 
 Right Left Anterior Posterior Inferior Superior 
TB0M 6  
(1-10) 
7 
(3-13) 
5 
(0-11) 
8 
(1-14) 
6 
(1-19) 
14 
(4-28) 
TBCW 4 
(1-12) 
3 
(1-5) 
6 
(1-13) 
3 
(1-8) 
6 
(2-13) 
5 
(3-10) 
TB5M 1 
(0-3) 
1 
(0-3) 
4 
(0-7) 
0 
(0-1) 
2 
(1-3) 
1 
(0-4) 
 
Table 2: Differences in centres-of-mass compared to TB6M (mm) (range) 
 Right-left Anterior-posterior Inferior-superior 
TB0M 7 (3-24) 4 (2-22) 11 (1-37) 
TBCW 5 (1-10) 4 (1-6)   6 (2-13) 
TB5M 2 (1-7) 2 (1-5)   3  (1-6) 
 
Table 3: Median conformity level indices between tumour bed volumes defined 
using different numbers of markers (range) 
 Median conformity level index (range) 
TB0M 0.15 (0.04-0.27) 
TBCW 0.19 (0.05-0.27) 
TB5M 0.32 (0.25-0.41) 
TB6M 0.31 (0.19-0.40) 
 
Table 4: Median TB volumes by observer (cm3) (range) 
 Observer 1 Observer 2 Observer 3 Observer 4 p 
TB0M 10.0 
(2.2-30.5) 
10.3 
(2.6-42.2) 
2.5 
(0.7-10.0) 
3.9 
(0.7-8.3) 
<0.001 
TBCW 20.7 
(2.1-68.8) 
7.8 
(1.0-48.4) 
3.0 
(1.2-7.3) 
4.3 
(2.2-14.0) 
 0.002 
TB5M 13.6 
(10.0-48.0) 
7.9 
(4.5-42.2) 
5.6 
(3.4-14.1) 
5.2 
(3.2-14.9) 
<0.001 
TB6M 18.1 
(10.0-61.0) 
11.9 
(3.5-44.8) 
5.2 
(1.8-9.7) 
7.1 
(4.8-9.0) 
<0.001 
 
